We are live on ! Find out more
VKTX icon

Viking Therapeutics
VKTX

144 hedge funds and large institutions have $260M invested in Viking Therapeutics in 2021 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 50 increasing their positions, 43 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

291% more call options, than puts

Call options by funds: $8.57M | Put options by funds: $2.19M

22% more capital invested

Capital invested by funds: $212M → $260M (+$47.5M)

16% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 43

10% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 20

4.29% more ownership

Funds ownership: 51.73% → 56.03% (+4.3%)

1% more funds holding

Funds holding: 143 → 144 (+1)

Holders
144
Holders Change
+1
Holders Change %
+0.7%
% of All Funds
2.53%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
50
Reduced
43
Closed
20
Calls
$8.57M
Puts
$2.19M
Net Calls
+$6.38M
Net Calls Change
+$4.46M

Top Buyers

1
State Street
State Street
Massachusetts
+$12M
2
Two Sigma Investments
Two Sigma Investments
New York
+$5.86M
3
IC
Ikarian Capital
Texas
+$5.1M
4
Two Sigma Advisers
Two Sigma Advisers
New York
+$3.96M
5
Citigroup
Citigroup
New York
+$2.92M

Top Sellers

1
ACH
ArrowMark Colorado Holdings
Colorado
-$6.04M
2
Northern Trust
Northern Trust
Illinois
-$2.46M
3
Group One Trading
Group One Trading
Illinois
-$1.82M
4
Citadel Advisors
Citadel Advisors
Florida
-$1.35M
5
Renaissance Technologies
Renaissance Technologies
New York
-$1.01M
Name Holding Trade Value Shares
Change 		Change in
Stake
PPA
26
Parametric Portfolio Associates
Washington
$1.64M +$480K +68,167 +36%
DMK
27
David M. Knott
$1.32M -$70.4K -10,000 -5%
Aviva
28
Aviva
United Kingdom
$1.31M +$130K +18,496 +10%
Susquehanna International Group
29
Susquehanna International Group
Pennsylvania
$1.3M -$505K -71,820 -26%
Wells Fargo
30
Wells Fargo
California
$1.21M -$738K -104,929 -35%
Invesco
31
Invesco
Georgia
$1.18M +$120K +16,996 +10%
Charles Schwab
32
Charles Schwab
California
$1.05M +$80K +11,372 +7%
RJFSA
33
Raymond James Financial Services Advisors
Florida
$1.03M +$201K +28,588 +21%
William Blair & Company
34
William Blair & Company
Illinois
$972K +$48.6K +6,910 +5%
Swiss National Bank
35
Swiss National Bank
Switzerland
$949K +$21.1K +3,000 +2%
ERSOT
36
Employees Retirement System of Texas
Texas
$878K – – –
CC
37
Cornerstone Capital
California
$845K +$36.4K +5,180 +4%
California Public Employees Retirement System
38
California Public Employees Retirement System
California
$843K – – –
FAIM
39
Financial Advocates Investment Management
Washington
$837K +$116K +16,500 New
AA
40
ALPS Advisors
Colorado
$835K +$3.3K +469 +0.4%
Morgan Stanley
41
Morgan Stanley
New York
$770K +$250K +35,558 +41%
RhumbLine Advisers
42
RhumbLine Advisers
Massachusetts
$726K -$38.8K -5,510 -5%
Squarepoint
43
Squarepoint
New York
$672K +$436K +61,907 +140%
UBS AM
44
UBS AM
Illinois
$634K -$200K -28,400 -22%
California State Teachers Retirement System (CalSTRS)
45
California State Teachers Retirement System (CalSTRS)
California
$625K -$5.75K -818 -0.8%
Victory Capital Management
46
Victory Capital Management
Texas
$615K -$33.7K -4,787 -5%
Bank of Montreal
47
Bank of Montreal
Ontario, Canada
$587K -$260K -36,992 -28%
State of Wisconsin Investment Board
48
State of Wisconsin Investment Board
Wisconsin
$563K – – –
BFM
49
Boothbay Fund Management
New York
$539K +$599K +85,140 New
Barclays
50
Barclays
United Kingdom
$517K +$197K +27,952 +52%
1
2
3 4 5

VKTX Hedge Fund Activity: Q1 2021 in Review

144 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Viking Therapeutics (VKTX) for Q1 2021, worth a combined $260M — up 22% from $212M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new VKTX positions and 20 closed out — a net gain of 2 holders — while 50 added to existing stakes and 43 trimmed.

The largest buyer was State Street, adding an estimated $12M. The largest seller was ArrowMark Colorado Holdings, cutting an estimated $6.04M.

  • 144 institutional investors held Viking Therapeutics (VKTX) as of Q1 2021, up from 143 in Q4 2020.
  • Funds reported $260M of Viking Therapeutics stock for Q1 2021, up 22% quarter-over-quarter.
  • 22 funds opened new Viking Therapeutics positions in Q1 2021 and 20 closed out, a net change of +2 holders.
  • The largest Viking Therapeutics buyer in Q1 2021 was State Street, an estimated $12M added.
  • The largest Viking Therapeutics seller in Q1 2021 was ArrowMark Colorado Holdings, an estimated $6.04M sold.

Based on aggregated 13F filings for Q1 2021.